Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
06/06/2007 | CN1974555A Process of producing pyridine product with content greater than 99% |
06/06/2007 | CN1319975C Camptothecin analogs and methods of preparation thereof |
06/06/2007 | CN1319965C 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides |
06/06/2007 | CN1319962C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
06/06/2007 | CN1319947C 4-aminopyridine preparation method |
06/06/2007 | CN1319946C Novel 2-pyridylethylbenzamide derivative |
06/06/2007 | CN1319644C Supported catalyst for pyridine synthesis by tetrahydrofurfuryl alcohol and preparation process thereof |
06/05/2007 | USRE39682 Enzyme inhibitors, for cancer therapy |
06/05/2007 | US7227035 Bis-aryl sulfonamides |
06/05/2007 | US7227034 Formylating a halogenated 4-aminobiphenyl by a Vilsmeier reaction, acidification by a Knoevenagel or Doebner condensation reaction, and hydrogenation; shorter synthesis route; further modifications with siloxane moiety for charge transport layers in electrographic devices |
06/05/2007 | US7227025 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine |
06/05/2007 | US7226950 Sodium channel modulators |
06/05/2007 | US7226944 As antitumor agent |
06/05/2007 | US7226936 Pyridinic sulfonamide derivatives method of production and use thereof |
06/05/2007 | US7226935 Hypoglycemic agent |
06/05/2007 | CA2269561C Naphthalene derivative and liquid crystal composition comprising the same |
06/05/2007 | CA2233298C Wood-protecting agent |
06/05/2007 | CA2225624C Hydrazine derivatives |
06/05/2007 | CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
05/31/2007 | WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
05/31/2007 | WO2007060484A1 Azetidine derivatives as glyt1 inhibitors |
05/31/2007 | WO2007060215A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them |
05/31/2007 | WO2007060166A1 New n-phenethylcarboxamide derivatives |
05/31/2007 | WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
05/31/2007 | WO2007060026A1 Urea derivatives useful as calcium receptor modulators |
05/31/2007 | WO2007059872A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
05/31/2007 | WO2007027651A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
05/31/2007 | WO2007022964A3 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
05/31/2007 | WO2007017687A3 Ep2 receptor agonists |
05/31/2007 | WO2006069388A3 Stabilized polymeric thiol reagents |
05/31/2007 | WO2006058700A8 Acetamide compounds as fungicides |
05/31/2007 | WO2005099688A3 Cyclic compounds |
05/31/2007 | US20070123670 Dithioester chain transfer agents for use in reversible addition fragmentation chain transfer (RAFT) polymerization of acrylamide monomers; low polydispersity |
05/31/2007 | US20070123551 Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
05/31/2007 | US20070123513 6-thiomorpholin-4-yl-pyridine-3-sulfonic acid 4-chloro-2-methoxy-benzoylamide; ammonium salt of3-methyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-sulfonic acid 4-chloro-2-methoxy-benzoylamide; anticarcinogenic agent |
05/31/2007 | US20070123512 Propionamide derivatives useful as androgen receptor modulators |
05/31/2007 | US20070123509 Carboxamide derivatives |
05/31/2007 | US20070123493 Benzamide derivative |
05/31/2007 | CA2630860A1 Urea derivatives useful as calcium receptor modulators |
05/31/2007 | CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions |
05/31/2007 | CA2630039A1 Azetidine derivatives as glyt1 inhibitors |
05/31/2007 | CA2629935A1 (r)-arylalkylamino derivatives and pharmaceutical compositions containing them |
05/31/2007 | CA2629544A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
05/30/2007 | EP1790638A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
05/30/2007 | EP1789633A2 Benzamide compounds |
05/30/2007 | EP1789410A1 Methylene dipiperidine derivatives |
05/30/2007 | EP1789393A2 Pyridinylamines |
05/30/2007 | EP1789392A2 Preparation of pyridonecarboxylic acid antibacterials |
05/30/2007 | EP1789391A1 Bivalent linkers and conjugates thereof |
05/30/2007 | EP1789390A2 Pyridyl inhibitors of hedgehog signalling |
05/30/2007 | EP1789044A1 Phenylaminopyridines |
05/30/2007 | EP1789041A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
05/30/2007 | EP1603923B1 Metal complexes |
05/30/2007 | EP1562940B1 Aryl sulfonamides |
05/30/2007 | EP1411053B1 Method for obtaining derivatives of (pyridil substituted)methyl|thio|benzimidazol |
05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
05/30/2007 | CN1972960A Processes for preparing eptifibatide |
05/30/2007 | CN1972925A Substituted bisarylurea derivatives |
05/30/2007 | CN1972922A 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
05/30/2007 | CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
05/30/2007 | CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
05/30/2007 | CN1972908A N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
05/30/2007 | CN1972898A Process for the preparation of enantiomerically enriched beta amino acid derivatives |
05/30/2007 | CN1972897A Novel hexafluoroisopropanol derivatives |
05/30/2007 | CN1972884A Molecularly imprinted polymers selective for nitrosamines and methods of using the same |
05/30/2007 | CN1970559A Beta-carboline alkaloid, their preparation method and use |
05/30/2007 | CN1970553A 5-amido-2-[(4-methoxyl-3-methyl-2-pyridinyl)-methylthio]-1-hydro-benzimidazole and its derivative synthesis method |
05/30/2007 | CN1970543A Synthesis and uses of serial ion liquid as candidate drug with anticancer activity |
05/30/2007 | CN1970541A Method for preparing 3,5,6-trichloro pyridine-2-sodium alcoholate without solvent |
05/30/2007 | CN1318431C Process for production of heteroaryl-type boron compounds with iridium catalyst |
05/30/2007 | CN1318408C Azo hetercyle beta-elemene derivative and its preparation method and uses |
05/30/2007 | CN1318405C Azo heterocycle beta-elemene piperazine alkyl derivative and its preparation and uses |
05/30/2007 | CN1318404C Aryl ureas as kinase inhibitors |
05/30/2007 | CN1318393C Process for the preparation of 4-haloalkylnicotinonitriles |
05/30/2007 | CN1318389C Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it |
05/30/2007 | CN1318388C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
05/29/2007 | US7223879 Reactibng transition metal with boron compound and sulfonate compound |
05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
05/29/2007 | US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases |
05/29/2007 | US7223791 Function regulator for retinoid relative receptor |
05/29/2007 | US7223780 Triazole-derivatives as blood clotting enzyme factor Xa inhibitors |
05/29/2007 | US7223778 5-substituted-2-arylpyridines |
05/29/2007 | US7223774 Benzamide 2-hydroxy-3-diaminoalkanes |
05/29/2007 | US7223764 Antilipemic agents; anticholesterol agents |
05/29/2007 | US7223355 Functional additive having UV-absorbing substituent and ink composition containing the same |
05/24/2007 | WO2007059157A1 Bisamide inhibitors of hedgehog signaling |
05/24/2007 | WO2007059015A1 Improved catalysts for alpha-olefin manufacture |
05/24/2007 | WO2007058927A1 Histone deacetylase inhibitors as therapeutics for neurological diseases |
05/24/2007 | WO2007057139A1 Microbiocides |
05/24/2007 | WO2007024860A3 Sulfonamides |
05/24/2007 | WO2006071960A3 Compositions and methods of treating cell proliferation disorders |
05/24/2007 | US20070117984 catalyst selectivity for cyanation or ammoxidation; produce 3-cyanopyridine from 3-methylpyridine by reacting with ammonia and oxygen and in presence of catalysts which contain transition metals in addition to vanadium and phosphorus, and a catalyst support |
05/24/2007 | US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi |
05/24/2007 | US20070117848 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis |
05/24/2007 | US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
05/24/2007 | US20070117822 Novel antimalarial baylis-hillman adducts and a process for the preparation thereof |
05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
05/24/2007 | US20070117761 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |